aflibercept
Drug Details
- Generic Name
- aflibercept
- Brand Names
- EYLEA, EYLEA HD
- Application Number
- BLA125387
- Sponsor
- Catalent Indiana, LLC
- NDC Codes
- 10
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVITREAL
- Active Ingredients
- AFLIBERCEPT-YSZY, AFLIBERCEPT
Indications and Usage
1 INDICATIONS AND USAGE EYLEA is indicated for the treatment of: EYLEA is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1.1 ) Macular Edema Following Retinal Vein Occlusion (RVO) ( 1.2 ) Diabetic Macular Edema (DME) ( 1.3 ) Diabetic Retinopathy (DR) ( 1.4 ) Retinopathy of Prematurity (ROP) ( 1.5 ) 1.1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) 1.2 Macular Edema Following Retinal Vein Occlusion (RVO) 1.3 Diabetic Macular Edema (DME) 1.4 Diabetic Retinopathy (DR) 1.5 Retinopathy of Prematurity (ROP)